DG
14
2
CMS
64
-3
PNC
59
4
CL
56
-2
FRT
38
-3
HST
57
5
NSC
67
5
KSS
33
-6
PM
50
-2
MOS
23
3
CMI
56
5
MTCH
48
4
ILMN
44
2
SIG
60
2
DOW
63
5
AEP
56
-3
SWKS
40
4
IPG
42
3
V
56
-8
ADSK
67
2
DG
14
2
CMS
64
-3
PNC
59
4
CL
56
-2
FRT
38
-3
HST
57
5
NSC
67
5
KSS
33
-6
PM
50
-2
MOS
23
3
CMI
56
5
MTCH
48
4
ILMN
44
2
SIG
60
2
DOW
63
5
AEP
56
-3
SWKS
40
4
IPG
42
3
V
56
-8
ADSK
67
2
Financhill
Back

Paramount Group 10K Form

Buy
57

PGRE
Paramount Group

Last Price:
5.03
Seasonality Move:
1.61%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive PGRE News And Ratings

See the #1 stock for the next 7 days that we like better than PGRE

PGRE Financial Statistics

Sales & Book Value

Annual Sales: $742.79M
Cash Flow: $66.97M
Price / Cash Flow: 4.06
Annual Sales: $14.63
Price / Book: 0.35

Profitability

EPS (TTM): -0.98000
Net Income (TTM): $-211.89M
Gross Margin: $448.82M
Return on Equity: -5.09%
Return on Assets: -2.62%

Paramount Group Earnings Forecast

Key Paramount Group Financial Ratios

  • The Gross Profit Margin over the past 13 years for PGRE is 60.42%.
  • The Selling, General & Administrative Expenses for PGRE have been equal to 8.35% of Gross Profit Margin.
  • The Research & Development expenses have been 0.00% of Revenue.
  • The Interest Expense is -56.51% of Operating Income.
  • The Net Earning history of PGRE is -34.97% of Total Revenues.
  • Per Share Earnings over the last 13 years have been positive in 5 years.

Paramount Group Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Office REITs
Sector: Real Estate
Current Symbol: PGRE
CUSIP: 69924R
Website: pgre.com

Debt

Debt-to-Equity Ratio: 1.15
Current Ratio: 7.05
Quick Ratio: 5.67

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

PGRE Technical Analysis vs Fundamental Analysis

Buy
57
Paramount Group (PGRE) is a Buy

Is Paramount Group a Buy or a Sell?

  • Paramount Group stock is rated a Buy
    The current Paramount Group [PGRE] share price is $5.17. The Score for PGRE is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.